Skip to content
Stop using now Drug recall · FDA · Published April 6, 2021

PremierZen Black 5000 Recall: Unapproved Drug with Tadalafil

Hyobin LLC recalls PremierZen Black 5000 capsules distributed by Yolo Studio due to the presence of undeclared tadalafil.

🇺🇸 FDA recall #D-0382-2021DrugPremierZen ›
Take action

Contact the company

Recalling firmHyobin LLC455 S Pleasant Ave · Ridgewood, NJ 07450-5413
✎ GovInfoNow plain-language explainer

Hyobin LLC is recalling PremierZen Black 5000, a product marketed as a dietary supplement but found to contain tadalafil, an ingredient in prescription erectile dysfunction medications. The FDA determined the product was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). Because it contains an unapproved drug ingredient, it poses health risks not associated with standard supplements. Read more at govinfonow.com/recall/36218-premierzen-black-5000-recall-unapproved-drug-with-tadalafil.

Source Summary by GovInfoNow · govinfonow.com/recall/36218-premierzen-black-5000-recall-unapproved-drug-with-tadalafil · Updated October 11, 2026 · FDA enforcement record: FDA #D-0382-2021

Cite this page

“PremierZen Black 5000 Recall: Unapproved Drug with Tadalafil.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/36218-premierzen-black-5000-recall-unapproved-drug-with-tadalafil. Based on FDA recall #D-0382-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0382-2021%22&limit=1).

The Food and Drug Administration announced on April 6, 2021, that Hyobin LLC is recalling PremierZen Black 5000 Capsules. The product was marketed without an approved New Drug Application or Abbreviated New Drug Application. FDA analysis detected the presence of tadalafil in the capsules.

How to tell if you have it

  • Brand: PremierZen
  • Product: PremierZen Black 5000 Capsules
  • Packaging: Cardboard blisters containing one capsule per card
  • Distributor: Yolo Studio, Cliffside Park, NJ
  • Quantity: 500 cards
  • Distribution: USA Nationwide

The hazard

The FDA stated that the product was marketed without an approved New Drug Application or Abbreviated New Drug Application. Analysis results obtained by the agency found the presence of tadalafil in the capsules.

Context

GovInfoNow's records show other recent recalls of similar products include StuffbyNainax MR 7 SUPER 700000 Capsules (2025-12-15) and Shoolin Pharma Chem Tadalafil 500g Recall (2026-08-03). SUN PHARMACEUTICAL Xyvona 3mg Tablets Recall occurred on 2026-05-22 following an FDA denial of marketing.

How to tell if you have this one

Look for PremierZen Black 5000 packaged in cardboard blisters containing one capsule per card. The product was distributed nationwide by Yolo Studio of Cliffside Park, NJ. All lots are included in this recall.

  • Brand
    PremierZen
  • Category
    Drug
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    USA Nationwide
Recall numberProduct, codes & lotsQuantity
D-0381-2021PremierZen Extreme 3000, packaged in cardboard blisters containing one capsule per card, Distributed by Yolo Studio, Cliffside Park, NJ; all lots500 cards
D-0382-2021PremierZen Black 5000, packaged in cardboard blisters containing one capsule per card, Distributed by Yolo Studio, Cliffside Park, NJ; all lots500 cards
D-0383-2021Triple SupremeZen Plus 3500, packaged in cardboard blisters containing one capsule per card, Distributed by Yolo Studio, Cliffside Park, NJ; all lots300 cards
Based on the official FDA remedy

What to do — step by step

  1. Stop using the product

    Cease consumption of PremierZen Black 5000 immediately due to the presence of unapproved tadalafil.

  2. Dispose of the product

    Discard any remaining capsules or return them as instructed by the distributor, though specific disposal instructions are not provided in this record.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “USA Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 50 days after the firm started it.

1. Firm started the recall: Apr 6, 202112. FDA classified it Class II: May 14, 202123. Published in FDA’s Enforcement Report: May 26, 202132021
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0382-2021 (April 6, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0382-2021 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA